Logo

American Heart Association

  2
  0


Final ID: Su1145

A platelet biosignature in psoriasis associates with enhanced cardiovascular risk

Abstract Body (Do not enter title and authors here): Introduction: Studies display an increased cardiovascular (CV) risk in psoriasis, but the underlying mechanisms and prevention strategies are not known. We investigated platelet aggregation and the platelet transcriptome as one potential mechanism to explain CV risk in psoriasis.
Methods: Recruited psoriasis and controls (from the community) underwent platelet aggregation studies with light transmission aggregometry, and a subset underwent bulk platelet RNA sequencing with downstream analyses in R Studio.
Results: Psoriasis subjects (n=75, age 47 ± 15 years, percent body surface area of psoriasis 6%) compared to controls (n=44, age 41 ± 15 years) were older (p=0.02), overweight, (BMI [kg/m2] 28 ± 6 vs. 26 ± 5, p<0.01), more often carried a diagnosis of dyslipidemia (35% vs. 16% p=0.03) and had higher high-sensitivity C-reactive protein values ([hsCRP in mg/L 3.1 ± 4.5 vs. 1.8 ± 2.5, p=0.02). Platelet aggregation was significantly higher in psoriasis vs. controls with collagen (86.6% vs. 72.0%, p=0.03) and ADP (88.2% vs. 75.7% vs. p=0.03). Platelet RNA sequencing revealed in psoriasis vs. control 384 genes upregulated and 414 genes downregulated (p<0.05). Hierarchical clustering of the differentially expressed platelet RNA genes allowed a natural separation into three groups including one predominantly encompassing controls (18/20), a middle group (psoriasis = 24, controls = 20), and a third group of predominantly psoriasis (psoriasis = 25/26). Pathway analysis showed dysregulated TNF, interferon, and VEGF signaling pathways. Using penalized lasso regression, a psoriasis platelet RNA signature comprised of 400 differentially expressed platelet genes correlated with arterial stiffness (r=0.3, p=0.02), coronary plaque (r=0.5, p=0.02), and coronary calcium (r=0.5, p=0.02) burden.
Conclusion: Platelet aggregation is significantly increased in psoriasis with the platelet transcriptome associated with pro-inflammatory pathways and CV risk. Our results warrant further investigation of platelet involvement driving the heightened CV risk observed in psoriasis.
  • Drenkova, Kamelia  ( NYU Langone Health , New York , New York , United States )
  • Lo Sicco, Kristen  ( NYU Langone Health , New York , New York , United States )
  • Berger, Jeffrey  ( NYU Langone Health , New York , New York , United States )
  • Garshick, Michael  ( NYU Langone Health , New York , New York , United States )
  • Kazatsker, Filipp  ( NYU Langone Health , New York , New York , United States )
  • Muller, Matthew  ( New York University , New York City , New York , United States )
  • Schlamp, Florencia  ( NYU Langone Health , New York , New York , United States )
  • Luttrell-williams, Elliot  ( NYU Langone Health , New York , New York , United States )
  • Liberow, Sarah  ( NYU Langone Health , New York , New York , United States )
  • Mcgirl, Siobhan  ( NYU Langone Health , New York , New York , United States )
  • Kennedy, Lauren  ( NYU Langone Health , New York , New York , United States )
  • Garelik, Jessica  ( NYU Langone Health , New York , New York , United States )
  • Author Disclosures:
    Kamelia Drenkova: DO NOT have relevant financial relationships | Kristen Lo Sicco: DO have relevant financial relationships ; Consultant:Pfizer:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Consultant:Aquis:Active (exists now) | Jeffrey Berger: DO NOT have relevant financial relationships | Michael Garshick: DO have relevant financial relationships ; Consultant:Kiniksa:Active (exists now) ; Consultant:Horizon Therapeutics:Active (exists now) ; Consultant:Agepha:Active (exists now) ; Consultant:BMS:Active (exists now) | Filipp Kazatsker: DO NOT have relevant financial relationships | Matthew Muller: DO NOT have relevant financial relationships | Florencia Schlamp: No Answer | Elliot Luttrell-Williams: DO NOT have relevant financial relationships | Sarah Liberow: DO NOT have relevant financial relationships | Siobhan McGirl: DO NOT have relevant financial relationships | Lauren Kennedy: No Answer | Jessica Garelik: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

PVD Potpourri 2

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
A Polygenic Score to Identify Risk of Incident Stroke and Benefit from Primary Prevention Statin Therapy

Mcclintick Daniel, Kamanu Frederick, Melloni Giorgio, Sabatine Marc, Ruff Christian, Ridker Paul, Chasman Daniel, Marston Nicholas

A Meta-analysis of Folic Acid Supplementation Efficacy in Cardiovascular Diseases Prevention.

Calderon Martinez Ernesto, Camacho Davila Karen Fabiola, Pinto-colmenarez Rafael, Arruarana Victor, Arvelaez Pascucci Joanne, Castillo Jaqueline Livier, Alonso Ramirez Angie Carolina, Ghattas Patricia, Giron De Marza Maria, Sosaya Zuñiga Briggitte Solange, Martinez Lilan Jonathan David, Paredes Romero Enrique

More abstracts from these authors:
Platelet Transcriptomic Profiling in Acute Myocardial Infarction

Barrett Tessa, Reynolds Harmony, Berger Jeffrey, Schlamp Florencia, Muller Matthew, Lee Angela, Cornwell Macintosh, Luttrell-williams Elliot, Smilowitz Nathaniel, Hochman Judith, Ruggles Kelly

Platelets induce endothelial cell mitochondrial dysfunction in myocardial infarction

Sun Haoyu, Schlamp Florencia, Liberow Sarah, Smilowitz Nathaniel, Hochman Judith, Reynolds Harmony, Barrett Tessa, Berger Jeffrey

You have to be authorized to contact abstract author. Please, Login
Not Available